Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches

Background A consensus of experts has proposed to replace the term nonalcoholic fatty liver disease (NAFLD), whose global prevalence is 25%, with metabolic dysfunction‐associated fatty liver disease (MAFLD), to describe more appropriately the liver disease related to metabolic derangements. MAFLD is...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of clinical investigation Vol. 51; no. 7; pp. e13519 - n/a
Main Authors:	Dongiovanni, Paola, Paolini, Erika, Corsini, Alberto, Sirtori, Cesare R., Ruscica, Massimiliano
Format:	Journal Article
Language:	English
Published:	England Blackwell Publishing Ltd 01-07-2021
Subjects:	Abnormalities Acyltransferases - genetics Calcification Calcification (ectopic) Cardiovascular diseases Cardiovascular Diseases - epidemiology cardiovascular risk Coronary Artery Disease - epidemiology Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - epidemiology Diet Dyslipidemia Dyslipidemias - epidemiology Endothelium, Vascular - physiopathology Environmental factors Epidemiology Fatty liver Genetic analysis Genetic diversity Genetic variance Health risks Heart Disease Risk Factors Heart diseases Humans Hypertension Lipase - genetics Liver Liver diseases MAFLD MBOAT7 Membrane Proteins - genetics Mendelian Randomization Analysis Metabolic Syndrome - epidemiology Metabolism NAFLD Non-alcoholic Fatty Liver Disease - epidemiology Obesity Obesity - epidemiology Pathogenesis PCSK7 PCSK9 Plaque, Atherosclerotic - epidemiology Plaques PNPLA3 Risk Stiffness Thromboembolism TM6F2 Vascular Calcification - epidemiology Vascular Stiffness MAFLD NAFLD MBOAT7 PNPLA3 PCSK9 TM6F2 PCSK7 cardiovascular risk
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!